Benjamin Burnett
Stock Analyst
(2.05)
# 4,648
Out of 4,648 analysts
64
Total ratings
40.91%
Success rate
-5.61%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Benjamin Burnett
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACLX Arcellx | Maintains: Buy | $83 → $122 | $86.44 | +41.14% | 5 | Oct 18, 2024 | |
| BEAM Beam Therapeutics | Maintains: Buy | $66 → $69 | $24.36 | +183.25% | 2 | Sep 11, 2024 | |
| IDYA IDEAYA Biosciences | Maintains: Buy | $63 → $68 | $30.00 | +126.67% | 7 | Sep 10, 2024 | |
| CRSP CRISPR Therapeutics AG | Maintains: Hold | $60 → $59 | $50.59 | +16.62% | 5 | Aug 6, 2024 | |
| PGEN Precigen | Maintains: Buy | $7 → $10 | $0.81 | +1,130.31% | 3 | Jun 3, 2024 | |
| ALLO Allogene Therapeutics | Maintains: Hold | $4.4 → $4.6 | $3.00 | +53.33% | 5 | May 14, 2024 | |
| IRON Disc Medicine | Maintains: Buy | $71 → $73 | $58.25 | +25.32% | 5 | Apr 8, 2024 | |
| ATRA Atara Biotherapeutics | Maintains: Hold | $120 → $58 | $11.63 | +394.41% | 4 | Apr 1, 2024 | |
| RPTX Repare Therapeutics | Maintains: Buy | $16 → $17 | $3.58 | +374.86% | 4 | Sep 25, 2023 | |
| RVMD Revolution Medicines | Maintains: Buy | $37 → $47 | $55.87 | -15.88% | 3 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $11.44 | +118.53% | 11 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $5.3 → $5 | $2.76 | +81.16% | 2 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $690 → $780 | $8.29 | +9,308.93% | 2 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $22 → $24 | $1.33 | +1,704.51% | 2 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $16 | $1.74 | +819.54% | 1 | Jan 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $94 → $70 | $0.46 | +15,018.79% | 3 | Mar 27, 2020 |
Arcellx
Oct 18, 2024
Maintains: Buy
Price Target: $83 → $122
Current: $86.44
Upside: +41.14%
Beam Therapeutics
Sep 11, 2024
Maintains: Buy
Price Target: $66 → $69
Current: $24.36
Upside: +183.25%
IDEAYA Biosciences
Sep 10, 2024
Maintains: Buy
Price Target: $63 → $68
Current: $30.00
Upside: +126.67%
CRISPR Therapeutics AG
Aug 6, 2024
Maintains: Hold
Price Target: $60 → $59
Current: $50.59
Upside: +16.62%
Precigen
Jun 3, 2024
Maintains: Buy
Price Target: $7 → $10
Current: $0.81
Upside: +1,130.31%
Allogene Therapeutics
May 14, 2024
Maintains: Hold
Price Target: $4.4 → $4.6
Current: $3.00
Upside: +53.33%
Disc Medicine
Apr 8, 2024
Maintains: Buy
Price Target: $71 → $73
Current: $58.25
Upside: +25.32%
Atara Biotherapeutics
Apr 1, 2024
Maintains: Hold
Price Target: $120 → $58
Current: $11.63
Upside: +394.41%
Repare Therapeutics
Sep 25, 2023
Maintains: Buy
Price Target: $16 → $17
Current: $3.58
Upside: +374.86%
Revolution Medicines
Sep 21, 2023
Maintains: Buy
Price Target: $37 → $47
Current: $55.87
Upside: -15.88%
Sep 15, 2023
Reiterates: Buy
Price Target: $25
Current: $11.44
Upside: +118.53%
May 4, 2023
Maintains: Hold
Price Target: $5.3 → $5
Current: $2.76
Upside: +81.16%
Sep 10, 2021
Maintains: Buy
Price Target: $690 → $780
Current: $8.29
Upside: +9,308.93%
Jun 28, 2021
Upgrades: Buy
Price Target: $22 → $24
Current: $1.33
Upside: +1,704.51%
Jan 6, 2021
Initiates: Hold
Price Target: $16
Current: $1.74
Upside: +819.54%
Mar 27, 2020
Upgrades: Buy
Price Target: $94 → $70
Current: $0.46
Upside: +15,018.79%